Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.
Hynninen J, Kemppainen J, Lavonius M, Virtanen J, Matomäki J, Oksa S, Carpén O, Grénman S, Seppänen M, Auranen A. Hynninen J, et al. Among authors: virtanen j. Gynecol Oncol. 2013 Nov;131(2):389-94. doi: 10.1016/j.ygyno.2013.08.023. Epub 2013 Aug 29. Gynecol Oncol. 2013. PMID: 23994535 Clinical Trial.
FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
Hynninen J, Auranen A, Carpén O, Dean K, Seppänen M, Kemppainen J, Lavonius M, Lisinen I, Virtanen J, Grénman S. Hynninen J, et al. Among authors: virtanen j. Gynecol Oncol. 2012 Jul;126(1):64-8. doi: 10.1016/j.ygyno.2012.04.023. Epub 2012 Apr 24. Gynecol Oncol. 2012. PMID: 22542580 Clinical Trial.
18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer.
Vallius T, Hynninen J, Kemppainen J, Alves V, Auranen K, Matomäki J, Oksa S, Virtanen J, Grénman S, Auranen A, Seppänen M. Vallius T, et al. Among authors: virtanen j. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1224-1232. doi: 10.1007/s00259-018-3961-z. Epub 2018 Feb 23. Eur J Nucl Med Mol Imaging. 2018. PMID: 29476227
Clinical Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Response Evaluation after Primary Treatment of Advanced Epithelial Ovarian Cancer.
Hynninen J, Laasik M, Vallius T, Kemppainen J, Grönroos S, Virtanen J, Casado J, Hautaniemi S, Grenman S, Seppänen M, Auranen A. Hynninen J, et al. Among authors: virtanen j. Clin Oncol (R Coll Radiol). 2018 Aug;30(8):507-514. doi: 10.1016/j.clon.2018.04.007. Epub 2018 May 9. Clin Oncol (R Coll Radiol). 2018. PMID: 29753662 Clinical Trial.
11C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial).
Salminen A, Jambor I, Merisaari H, Ettala O, Virtanen J, Koskinen I, Veskimae E, Sairanen J, Taimen P, Kemppainen J, Minn H, Boström PJ. Salminen A, et al. Among authors: virtanen j. Cancer Imaging. 2018 Aug 2;18(1):25. doi: 10.1186/s40644-018-0158-4. Cancer Imaging. 2018. PMID: 30068379 Free PMC article. Clinical Trial.
PET/CT for Evaluation of Ovarian Cancer.
Kemppainen J, Hynninen J, Virtanen J, Seppänen M. Kemppainen J, et al. Among authors: virtanen j. Semin Nucl Med. 2019 Nov;49(6):484-492. doi: 10.1053/j.semnuclmed.2019.06.010. Epub 2019 Jul 4. Semin Nucl Med. 2019. PMID: 31630732 Review.
521 results